首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   37880篇
  免费   2264篇
  国内免费   199篇
耳鼻咽喉   372篇
儿科学   808篇
妇产科学   762篇
基础医学   5113篇
口腔科学   1997篇
临床医学   2833篇
内科学   9717篇
皮肤病学   984篇
神经病学   3378篇
特种医学   798篇
外国民族医学   4篇
外科学   5496篇
综合类   174篇
一般理论   10篇
预防医学   3054篇
眼科学   755篇
药学   2126篇
中国医学   198篇
肿瘤学   1764篇
  2023年   286篇
  2022年   381篇
  2021年   1434篇
  2020年   801篇
  2019年   1219篇
  2018年   1500篇
  2017年   889篇
  2016年   916篇
  2015年   1146篇
  2014年   1577篇
  2013年   1952篇
  2012年   2897篇
  2011年   3198篇
  2010年   1690篇
  2009年   1518篇
  2008年   2405篇
  2007年   2464篇
  2006年   2327篇
  2005年   2105篇
  2004年   1875篇
  2003年   1675篇
  2002年   1555篇
  2001年   458篇
  2000年   464篇
  1999年   425篇
  1998年   283篇
  1997年   238篇
  1996年   200篇
  1995年   162篇
  1994年   135篇
  1993年   149篇
  1992年   216篇
  1991年   205篇
  1990年   193篇
  1989年   123篇
  1988年   109篇
  1987年   88篇
  1986年   116篇
  1985年   110篇
  1984年   85篇
  1983年   67篇
  1982年   65篇
  1981年   60篇
  1979年   49篇
  1978年   42篇
  1976年   35篇
  1974年   35篇
  1972年   36篇
  1971年   37篇
  1970年   37篇
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
991.

Introduction

Thiopurine therapy can be optimised by determining the concentration of the drug's metabolites.

Patients and methods

Retrospective analysis on a prospective database of 31 patients with inflammatory bowel disease who failed therapy with thiopurines. Thiopurine metabolites (6-thioguanine, 6-TGN and 6-methylmercaptopurine, 6-MMP) were measured by high-performance liquid chromatography (Laboratorios Cerba, Barcelona) and treatment was duly adjusted in accordance with the results. Clinical response was reassessed after six months.

Result

Despite the appropriate theoretical dose of thiopurines being administered, the dose was insufficient in 45.6% of patients (nonadherence to treatment suspected in 6.45%) and 16.2% received an excessive dose or the drug was metabolised by other metabolic pathways. After treatment was optimised based on metabolite levels, only 25.8% (8/31) were prescribed a biological agent, while 74.2% of cases (23/31) were managed through dose optimisation alone.

Discussion

Monitoring thiopurine metabolite levels may help clinicians to assess non-responsive patients before adding or switching to another drug (generally a biological agent), thereby avoiding any additional costs or potential toxicity. This strategy may also help to identify patients receiving an insufficient dose and those with an alternative metabolic pathway, who could be candidates for low-dose AZA with allopurinol, as well as patients who are suspected of being non-adherent. In three out of four patients, switching to a biological agent can be avoided.  相似文献   
992.

Objective

This study was conducted to estimate oral colonization by Streptococcus mutans and Streptococcus sanguinis in adults with high and without any caries experience. Furthermore, differences in the amount of hydrogen peroxide (H2O2) produced by S. sanguinis isolated from both groups were assessed.

Design

Forty adults were divided into: (i) carious lesion-free, without any carious lesion, assessed by the International Caries Detection and Assessment System (ICDAS), or restoration, (CF) and (ii) high caries experience (HC). Saliva samples were collected and seeded on respective agar-plates for enumeration of total streptococci, S. mutans and S. sanguinis (CFU/mL) and compared between groups. Additionally, S. sanguinis colonies obtained from both groups were inoculated on Prussian blue agar for H2O2 detection. Production of H2O2 was quantified and compared between the two groups. S. sanguinis counts were significantly higher in CF than HC individuals (p < 0.05). Conversely, S. mutans showed significantly higher levels in HC than CF subjects (p < 0.001). S. sanguinis colonies from CF individuals produced significantly larger H2O2 halos compared with HC subjects.

Conclusions

S. sanguinis predominates over S. mutans in saliva of adults without caries experience. In those people, S. sanguinis produces more H2O2ex vivo.  相似文献   
993.
994.
995.
996.
997.
Over the past decade, point‐of‐care ultrasound has become a common tool used for both procedures and diagnosis. Developing high‐fidelity phantoms is critical for training in new and novel point‐of‐care ultrasound applications. Detecting skull fractures on ultrasound imaging in the younger‐than‐2‐year‐old patient is an emerging area of point‐of‐care ultrasound research. Identifying a skull fracture on ultrasound imaging in this age group requires knowledge of the appearance and location of sutures to distinguish them from fractures. There are currently no commercially available pediatric skull fracture models. We outline a novel approach to building a cost‐effective, simple, high‐fidelity pediatric skull fracture phantom to meet a unique training requirement.  相似文献   
998.
999.
1000.
Umbilical cord blood (UCB) transplantation has observed a significant increase in recent years, due to the unique features of UCB haematopoietic stem/progenitor cells (HSCs) for the treatment of blood‐related disorders. However, the low cell numbers available per UCB unit significantly impairs the widespread use of this source for transplantation of adult patients, resulting in graft failure, delayed engraftment and delayed immune reconstitution. In order to overcome this issue, distinct approaches are now being considered in clinical trials, such as double‐UCB transplantation, intrabone injection or ex vivo expansion. In this article the authors review the current state of the art, future trends and challenges on the ex vivo expansion of UCB HSCs, focusing on culture parameters affecting the yield and quality of the expanded HSC grafts: novel HSC selection schemes prior to cell culture, cytokine/growth factor cocktails, the impact of biochemical factors (e.g. O2) or the addition of supportive cells, e.g. mesenchymal stem/stromal cell (MSC)‐based feeder layers) were addressed. Importantly, a critical challenge in cellular therapy is still the scalability, reproducibility and control of the expansion process, in order to meet the clinical requirements for therapeutic applications. Efficient design of bioreactor systems and operation modes are now the focus of many bioengineers, integrating the increasing 'know‐how' on HSC biology and physiology, while complying with the GMP standards for the production of cellular products, i.e. through the use of commercially available, highly controlled, disposable technologies. Copyright © 2013 John Wiley & Sons, Ltd.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号